The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis
Open accessAbstract
A growing body of evidence indicates that resolution of acute inflammation is an active process. Resolvins are a new family of lipid mediators enzymatically generated within resolution networks that possess unique and specific functions to orchestrate catabasis, the phase in which disease declines. Resolvin D2 (RvD2) was originally identified in resolving exudates, yet its individual contribution in resolution remained to be elucidated. Here, we establish RvD2's potent stereoselective actions in reducing excessive neutrophil trafficking to inflammatory loci. RvD2 decreased leukocyte-endothelial interactions in vivo by endothelial-dependent nitric oxide production, and by direct modulation of leukocyte adhesion receptor expression. In mice with microbial sepsis initiated by caecal ligation and puncture, RvD2 sharply decreased both local and systemic bacterial burden, excessive cytokine production and neutrophil recruitment, while increasing peritoneal mononuclear cells and macrophage phagocytosis. These multi-level pro-resolving actions of RvD2 translate to increased survival from sepsis induced by caecal ligation and puncture and surgery. Together, these results identify RvD2 as a potent endogenous regulator of excessive inflammatory responses that acts via multiple cellular targets to stimulate resolution and preserve immune vigilance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“From a translational perspective, SPMs suppress inflammation but, unlike anti-inflammatory drugs, these pro-resolving mediators promote both repair and continued pathogen clearance33,213–215.”
From Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities (2019) · cites this paper as [215]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144
The Pathophysiology and Treatment of Sepsis
Hotchkiss, R. S., & Karl, I. E. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021333 · Cited by 4,134
Nitric oxide: an endogenous modulator of leukocyte adhesion.
Kubes, P., Suzuki, M., & Granger, D. N. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.4651 · Cited by 3,036
Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators
Serhan, C. N., Chiang, N., & Van Dyke, T. E. (2008) · Nature Reviews Immunology · doi:10.1038/nri2294 · Cited by 2,932
Self-citationImmunodesign of experimental sepsis by cecal ligation and puncture
Rittirsch, D., Huber-Lang, M. S., Flierl, M. A., & Ward, P. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.214 · Cited by 2,209
Serhan, C. N., Hong, S., Gronert, K., Colgan, S. P., Devchand, P. R., Mirick, G., & Moussignac, R.-L. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020760 · Cited by 1,650
Self-citationDombrovskiy, V. Y., Martin, A. A., Sunderram, J., & Paz, H. L. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000261890.41311.e9 · Cited by 1,253
Hong, S., Gronert, K., Devchand, P. R., Moussignac, R.-L., & Serhan, C. N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300218200 · Cited by 1,000
Self-citationThe discovery of nitric oxide and its role in vascular biology
Moncada, S., & Higgs, E. A. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706458 · Cited by 863
Animal Models of sepsis: setting the stage
Buras, J. A., Holzmann, B., & Sitkovsky, M. V. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1854 · Cited by 838
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 694
Kumagai, Y., Murakami, T., Kuwahara-Arai, Iba, T., Reich, J., & Nagaoka, I. (2020) · Innate Immunity · doi:10.1177/1753425920936754 · Cited by 26
Myeloid cell diversification during regenerative inflammation: Lessons from skeletal muscle
Patsalos, A., Tzerpos, P., Wei, X., & Nagy, L. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.05.005 · Cited by 28
Specialized Proresolving Lipid Mediators: A Potential Therapeutic Target for Atherosclerosis
Salazar, J. J., Pírela, D., Nava, M., Castro, A. V., Angarita, L., Parra, H., Durán‐Agüero, S., Rojas-Gómez, D. M., Galbán, N., Áñez, R., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063133 · Cited by 26
Emerging therapies in allergic conjunctivitis and dry eye syndrome
Nye, M., Rudner, S., & Bielory, L. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.802773 · Cited by 25
Menon, R., Krzyszczyk, P., & Francois Berthiaume, B. (2017) · Nano LIFE · doi:10.1142/s1793984417500027 · Cited by 25
Bioactive Lipids as Mediators of the Beneficial Action(s) of Mesenchymal Stem Cells in COVID-19
Das, U. N. (2020) · Aging and Disease · doi:10.14336/ad.2020.0521 · Cited by 24
Fitzgerald, H., Bonin, J. L., Khan, S., Eid, M., Sadhu, S., Rahtes, A., Lipscomb, M., Biswas, N., Decker, C., Nabage, M., et al. (2023) · American Journal Of Pathology · doi:10.1016/j.ajpath.2023.08.011 · Cited by 27
Self-citationTotal synthesis of the anti-inflammatory lipid mediator Resolvin E2
Rodrı́guez, A. R., & Spur, B. W. (2012) · Tetrahedron Letters · doi:10.1016/j.tetlet.2012.01.136 · Cited by 24
Benvenuti, F., Gatto, M., Larosa, M., Iaccarino, L., Punzi, L., & Doria, A. (2015) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2015.1073259 · Cited by 24
Mariqueo, T. A., & Zúñiga‐Hernández, J. (2020) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2020.102095 · Cited by 24
The Role of Specialized Pro-Resolving Mediators in Cystic Fibrosis Airways Disease
Briottet, M., Shum, M., & Urbach, V. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01290 · Cited by 26
Kidney and Liver Injuries After Major Burns in Rats Are Prevented by Resolvin D2
Inoue, Y., Yu, Y., Kurihara, T., Vasilyev, A., Ibrahim, A. E., Öklü, R., Zhao, G., Nair, A. V., Brown, D., Fischman, A. J., et al. (2015) · Critical Care Medicine · doi:10.1097/ccm.0000000000001397 · Cited by 24
Role of Inflammatory and Proresolving Mediators in Endothelial Dysfunction
Briones, A. M., Hernanz, R., García‐Redondo, A. B., Rodrı́guez, C., Blanco‐Colio, L. M., Val‐Blasco, A., Alonso, M. J., & Salaíces, M. (2025) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.70026 · Cited by 24
Deciphering the role of n-3 polyunsaturated fatty acid-derived lipid mediators in health and disease
Spite, M. R. (2013) · Proceedings of The Nutrition Society · doi:10.1017/s0029665113003030 · Cited by 25
Self-citationJoffre, J., Wong, E., Lawton, S., Lloyd, E., Nguyen, N. T., Xu, F., Sempio, C., Kobzik, L., Zlatanova, I., Schumacher, M. A., et al. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02485-z · Cited by 24
Molecular Circuits of Resolution in the Eye
Liclican, E. L., & Gronert, K. (2010) · The Scientific World JOURNAL · doi:10.1100/tsw.2010.99 · Cited by 22
Lipoxin A4 promotes reduction and antibiotic efficacy against Pseudomonas aeruginosa biofilm
Thornton, J. M., Walker, J. M., Sundarasivarao, P. Y. K., Spur, B. W., Rodríguez, A. R., & Yin, K. (2020) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2020.106505 · Cited by 24
Fatty acids and cardiac disease: fuel carrying a message
van Bilsen, M., & Planavila, A. (2014) · Acta Physiologica · doi:10.1111/apha.12308 · Cited by 22
Sundarasivarao, P. Y. K., Walker, J. M., Rodrı́guez, A. R., Spur, B. W., & Yin, K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1011944 · Cited by 23
Patients Requiring Perioperative Nutritional Support
Enomoto, T. M., Larson, D. M., & Martindale, R. G. (2013) · Medical Clinics of North America · doi:10.1016/j.mcna.2013.07.003 · Cited by 22
Theilla, M., Schwartz, B., Zimra, Y., Shapiro, H., Anbar, R., Rabizadeh, E., Cohen, J. D., & Singer, P. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114511004004 · Cited by 22
Can Inflammation-Resolution Provide Clues to Treat Patients According to Their Plaque Phenotype?
Fredman, G. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00205 · Cited by 22
Novel Resolution Mediators of Severe Systemic Inflammation
Gudernatsch, V., Stefanczyk, S. A., & Mirakaj, V. (2020) · ImmunoTargets and Therapy · doi:10.2147/itt.s243238 · Cited by 24
Bioactive lipid mediator class switching regulates myogenic cell progression and muscle regeneration
Fabre, P., Molina, T., Larose, J., Greffard, K., Généreux-Gamache, G., Deprez, A., Mokhtari, I., Pellerito, O., Duchesne, É., Dort, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-60586-8 · Cited by 24
Clinical significance of polyunsaturated fatty acids in the prevention of cardiovascular diseases
Kotlyarov, S. N., & Котлярова, А. А. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.998291 · Cited by 22
Dort, J., Orfi, Z., Fiscaletti, M., Campeau, P. M., & Dumont, N. A. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1187253 · Cited by 22
Faraji, P., Kühn, H., & Ahmadian, S. (2024) · Journal of Molecular Neuroscience · doi:10.1007/s12031-024-02224-4 · Cited by 25
Nshimiyimana, R., Simard, M., Teder, T., Rodrı́guez, A. R., Spur, B. W., Haeggström, J. Z., & Serhan, C. N. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2405821121 · Cited by 21
Self-citationCommon Therapeutic Targets in Cardiometabolic Disease
Fredman, G., Özcan, L., & Tabas, I. A. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008908 · Cited by 21
Is sepsis a pro-resolution deficiency disorder?
Das, U. N. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.12.007 · Cited by 21
Diaz, L. A., Altman, N. H., Khan, W. N., Serhan, C. N., & Adkins, B. (2017) · Infection and Immunity · doi:10.1128/iai.00464-17 · Cited by 21
Self-citationMartindale, R. G., Warren, M. M., & McClave, S. A. (2016) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000250 · Cited by 20
Matrix stiffness regulates bone repair by modulating 12-lipoxygenase-mediated early inflammation
Yao, D., Qiao, F., Song, C., & Lv, Y. (2021) · Materials Science and Engineering C · doi:10.1016/j.msec.2021.112359 · Cited by 21
Kim, S.-E., Lee, J. Y., An, J.-U., Kim, T.-H., Oh, C.-W., Ko, Y., Krishnan, M., Choi, J., Yoon, D., Kim, Y., et al. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2021.159091 · Cited by 20
Resolvin D2 limits atherosclerosis progression via myeloid cell‐GPR18
Lipscomb, M., Walis, S., Marinello, M., Mena, H. A., MacNamara, K. C., Spite, M. R., & Fredman, G. (2024) · The FASEB Journal · doi:10.1096/fj.202302336rr · Cited by 21
Self-citationContributions of neutrophils to resolution of mucosal inflammation
Colgan, S. P., Ehrentraut, S., Glover, L. E., Kominsky, D. J., & Campbell, E. L. (2012) · Immunologic Research · doi:10.1007/s12026-012-8350-2 · Cited by 20
Tómasdóttir, V., Víkingsson, A., Freysdóttir, J., & Harðardóttir, I. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2013.03.005 · Cited by 20
Can Specialized Pro-resolving Mediators Deliver Benefit Originally Expected from Fish Oil?
Rosenthal, M. D., Patel, J. J., Staton, K. M., Martindale, R. G., Moore, F. A., & Upchurch, G. R. (2018) · Current Gastroenterology Reports · doi:10.1007/s11894-018-0647-4 · Cited by 20
Gene expression profiling of sepsis‑associated acute kidney injury
Yang, J., Wu, B., Han, F., Chen, J., & Yang, Y. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.9161 · Cited by 20
Resolvin D1 Attenuates the Organ Injury Associated With Experimental Hemorrhagic Shock
Sordi, R., Chiazza, F., Collotta, D., Migliaretti, G., Colas, R. A., Vulliamy, P., Brohi, K., Dalli, J., Collino, M., & Thiemermann, C. (2019) · Annals of Surgery · doi:10.1097/sla.0000000000003407 · Cited by 20
Dhayal, S., & Morgan, N. G. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01145.x · Cited by 20
Low-dose pro-resolving mediators temporally reset the resolution response to microbial inflammation
Serhan, C. N., Chiang, N., & Nshimiyimana, R. (2024) · Molecular Medicine · doi:10.1186/s10020-024-00877-w · Cited by 21
Self-citationIdentification of 14,20-dihydroxy-docosahexaenoic acid as a novel anti-inflammatory metabolite
Yokokura, Y., Isobe, Y., Matsueda, S., Iwamoto, R., Goto, T., Yoshioka, T., Urabe, D., Inoue, M., Arai, H., & Arita, M. (2014) · The Journal of Biochemistry · doi:10.1093/jb/mvu044 · Cited by 20
Thornton, J. M., & Yin, K. (2021) · Molecules · doi:10.3390/molecules26226970 · Cited by 20
Leukotrienes in Innate Immunity: Still Underappreciated after All These Years?
Serezani, C. H., Divangahi, M., & Peters-Golden, M. L. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2200599 · Cited by 18
Pro-resolving metabolites: Future of the fish oil supplements
Maliha, A., Tahsin, M., Fabia, T. Z., Rahman, S. M., & Rahman, M. (2024) · Journal of Functional Foods · doi:10.1016/j.jff.2024.106439 · Cited by 22
Wu, B. C., Walker, J. A., Temmermand, D., Mian, K., Spur, B. W., Rodríguez, A. R., Stein, T. P., Banerjee, P., & Yin, K. (2013) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2013.04.005 · Cited by 19
Proresolving lipid mediators and liver disease
Clària, J., Flores‐Costa, R., Duran‐Güell, M., & López‐Vicario, C. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2021.159023 · Cited by 19
Das, U. N. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-016-0377-2 · Cited by 20
Yasmeen, N., Selvaraj, H., Lakhawat, S. S., Datta, M., Sharma, P. K., Jain, A., Khanna, R., Srinivasan, J., & Kumar, V. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115437 · Cited by 17
The therapeutic potential of resolvins in pulmonary diseases
Centanni, D., Henricks, P. A. J., & Engels, F. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.176047 · Cited by 18
Feng, X., Maze, M., Koch, L. G., Britton, S. L., & Hellman, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126906 · Cited by 18
Pro-Resolving Effects of Resolvin D2 in LTD4 and TNF-α Pre-Treated Human Bronchi
Khaddaj‐Mallat, R., Sirois, C., Sirois, M., Rizcallah, E., Marouan, S., Morin, C., & Rousseau, É. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167058 · Cited by 18
Resolvin D2 Limits Secondary Tissue Necrosis after Burn Wounds in Rats
Inoue, Y., Liu, Y.-M., Otawara, M., Calero, I. C., Nam, A., Yu, Y.-M., Chang, P., Butler, K. L., Nazarian, R., Goverman, J., et al. (2017) · Journal of Burn Care & Research · doi:10.1097/bcr.0000000000000617 · Cited by 17
GC, J. B., Szlenk, C. T., Gao, J., Dong, X., Wang, Z., & Natesan, S. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00299 · Cited by 18
Miek, L., Jordan, P. M., Günther, K., Pace, S., Beyer, T., Kowalak, D., Hoerr, V., Löffler, B., Tuchscherr, L. P. N., Serhan, C. N., et al. (2022) · Immunology · doi:10.1111/imm.13449 · Cited by 18
Self-citationSerial Changes in Plasma Annexin A1 and Cortisol Levels in Sepsis Patients
Tsai, W. (2014) · The Chinese Journal of Physiology · doi:10.4077/cjp.2014.bab193 · Cited by 18
Kolawole, O. R., & Kashfi, K. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177924 · Cited by 19
12/15-Lipoxygenase choreographs the resolution of IgG-mediated skin inflammation
Sezin, T., Ferreirós, N., Jennrich, M., Ochirbold, K., Seutter, M., Attah, C., Mousavi, S., Zillikens, D., Geißlinger, G., & Sadik, C. D. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102528 · Cited by 17
Resolvin D2 promotes host defense in a 2 - hit model of sepsis with secondary lung infection
Walker, J. M., Sundarasivarao, P. Y. K., Thornton, J. M., Sochacki, K., Rodríguez, A. R., Spur, B. W., Acharya, N. K., & Yin, K. (2022) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2022.106617 · Cited by 17
Wang, L., Li, J., Liao, R., Li, Y., Jiang, L., Zhang, Z., Geng, J., Fu, P., Su, B., & Zhao, Y. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e12269 · Cited by 20
Yang, L., Liu, T., Zhuo, Y., Li, D., Li, D., Liu, J., Gao, H., Zhang, L., Lin, J., & Wang, X. (2023) · Cellular Signalling · doi:10.1016/j.cellsig.2023.110768 · Cited by 17
Aldian, D., Harisa, L. D., Mitsuishi, H., Tian, K., Iwasawa, A., & Yayota, M. (2023) · animal · doi:10.1016/j.animal.2023.100981 · Cited by 17
Immunomodulation of periodontitis with SPMs
Sahni, V., & Dyke, T. E. V. (2023) · Frontiers in Oral Health · doi:10.3389/froh.2023.1288722 · Cited by 20
Wang, J., Ruan, J., Li, C., Wang, J.-M., Li, Y., Zhai, W., Zhang, W., Ye, H., Shen, N.-H., Lei, K.-F., et al. (2011) · Rheumatology International · doi:10.1007/s00296-011-1960-5 · Cited by 17
Effects of statins on liver cell function and inflammation in septic rats
Stolf, A. M., Lívero, F. A. D. R., Dreifuss, A. A., Bastos-Pereira, A. L., Fabossi, I. A., de Souza, C. E. A., Gomes, L. D. O., Chicorski, R., Brandt, A. P., Cadena, S. M. S. C., et al. (2012) · Journal of Surgical Research · doi:10.1016/j.jss.2012.08.019 · Cited by 17
The role of 15-LOX-1 in colitis and colitis-associated colorectal cancer
Mao, F., Wang, M., Wang, J., & Xu, W. (2015) · Inflammation Research · doi:10.1007/s00011-015-0852-7 · Cited by 17
Hopkin, S. J., Lewis, J. W., Krautter, F., Chimen, M., & McGettrick, H. M. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00184 · Cited by 17
Total synthesis of the endogenous inflammation resolving lipid resolvin D2 using a common lynchpin
Li, J., Leong, M. M., Stewart, A. G., & Rizzacasa, M. A. (2013) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.9.310 · Cited by 17
Ortega, Á., Durán, P., Garrido, B., Manzano, A., Navarro, C., Silva, A., Rojas, M., Sanctis, J. B. D., Radzioch, D., Rivera-Porras, D., et al. (2025) · Molecules · doi:10.3390/molecules30102212 · Cited by 17
Irún, P., Carrera‐Lasfuentes, P., Sánchez‐Luengo, M., Belío, Ú., Domper-Arnal, M. J., Higuera, G. A., Hawkins, M., de la Rosa, X., & Lanas, Á. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216143 · Cited by 16
Biringer, R. G. (2021) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-021-00630-6 · Cited by 16
Arnardottir, H. H., Freysdóttir, J., & Harðardóttir, I. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2012.05.012 · Cited by 16
Resolution Potential of Necrotic Cell Death Pathways
Mázló, A., Tang, Y., Jenei, V., Brauman, J., Yousef, H., Bácsi, A., & Koncz, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010016 · Cited by 16
Zhang, W.-W., Wang, S.-S., Ding, Y.-D., Wu, X., Chen, T., Gao, Y., Jin, S., & Zhang, P. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.02.026 · Cited by 15
Babar, M. U., Nassar, A. F., Nie, X., Zhang, T., He, J., Yeung, J. T., Norris, P. C., Ogura, H., Muldoon, A., Chen, L., et al. (2024) · Metabolites · doi:10.3390/metabo14060314 · Cited by 17
Targeting of G-protein coupled receptors in sepsis
Rehman, A., Baloch, N. U.-A., Morrow, J., Pacher, P., & Haskó, G. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107529 · Cited by 18
The regulatory effect of specialized pro-resolving mediators on immune cells
Pan, G., Zhang, P., Yang, J., & Wu, Y. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113980 · Cited by 16
Omics approaches in cystic fibrosis research: a focus on oxylipin profiling in airway secretions
Eiserich, J. P., Yang, J., Morrissey, B. M., Hammock, B. D., & Cross, C. E. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06580.x · Cited by 15
Das, U. N. (2021) · Lipids in Health and Disease · doi:10.1186/s12944-021-01507-8 · Cited by 16
A potent proresolving mediator 17R-resolvin D2 from human macrophages, monocytes, and saliva
Simard, M., Nshimiyimana, R., Chiang, N., Rodríguez, A. R., Spur, B. W., & Serhan, C. N. (2024) · Science Advances · doi:10.1126/sciadv.adq4785 · Cited by 14
Self-citationViral Infection and the Blood-Brain Barrier: Molecular Research Insights and Therapies
Boardman, S., Hetherington, C., Hughes, T., Cook, C., Galea, I., Hilton, O., Solomon, T., Luster, A. D., Allan, S. M., Kurt‐Jones, E. A., et al. (2025) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaf455 · Cited by 16
Dubé, L., Spahis, S., Lachaîne, K., Lemieux, A., Monhem, H., Poulin, S.-M., Randoll, C., Travaillaud, E., Ould-Chikh, N.-E.-H., Marcil, V., et al. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0156 · Cited by 15
Recent Developments in Severe Sepsis Research: From Bench to Bedside and Back
Raşid, O., & Cavaillon, J. (2016) · Future Microbiology · doi:10.2217/fmb.15.133 · Cited by 14
Brücher, B. L. D. M., & Jamall, I. S. (2019) · 4open · doi:10.1051/fopen/2018008 · Cited by 15
Lipid Mediators in Inflammation
Bennett, M., & Gilroy, D. W. (2017) · ASM Press eBooks · doi:10.1128/9781555819194.ch19 · Cited by 15
Diet and Respiratory Infections: Specific or Generalized Associations?
Vu, T. T., Horn, L. V., Achenbach, C. J., Rydland, K., & Cornelis, M. C. (2022) · Nutrients · doi:10.3390/nu14061195 · Cited by 16
Rodrigues‐Díez, R., Ballesteros‐Martínez, C., Moreno-Carriles, R. M., Nistal, F., del Campo, L. S. D., Cachofeiro, V., Dalli, J., García‐Redondo, A. B., Redondo, J. M., Salaíces, M., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116564 · Cited by 13
Soehnlein, O. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa5355 · Cited by 13
Hayford, F. E. A., Ozturk, M., Dolman, R., Blaauw, R., Nienaber, A., Loots, D. T., Brombacher, F., Smuts, C. M., Parihar, S. P., & Malan, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.659943 · Cited by 13
Nienaber, A., Ozturk, M., Dolman, R., Zandberg, L., Hayford, F. E. A., Brombacher, F., Blaauw, R., Smuts, C. M., Parihar, S. P., & Malan, L. (2021) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2021.102304 · Cited by 14
Lipid-Derived Mediators are Pivotal to Leukocyte and Lung Cell Responses in Sepsis and ARDS
Nijmeh, J., & Levy, B. D. (2021) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-021-01012-w · Cited by 13
Spite, M. R., & Fredman, G. (2023) · Advances in pharmacology · doi:10.1016/bs.apha.2022.12.005 · Cited by 13
Self-citationLung Inflammation Resolution by RvD1 and RvD2 in a Receptor-Dependent Manner
Gao, J., Su, Y., & Wang, Z. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15051527 · Cited by 13
Resolution of inflammation: examples of peptidergic players and pathways
Ahmed, T. J., Kaneva, M. K., Pitzalis, C., Cooper, D., & Perretti, M. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.05.020 · Cited by 13
Self-citationIida, J., ISHII, S., Nakajima, Y., Sessler, D. I., Teramae, H., Kageyama, K., Maeda, S., Anada, N., Shibasaki, M., Sawa, T., et al. (2019) · British Journal of Anaesthesia · doi:10.1016/j.bja.2019.03.040 · Cited by 13
Peh, H. Y., Brüggemann, T. R., Duvall, M. G., Nshimiyimana, R., Nijmeh, J., Cinelli, M. A., Israel, E., Serhan, C. N., & Levy, B. D. (2023) · Allergy · doi:10.1111/all.15920 · Cited by 12
Self-citationResolvin D2 attenuates LPS ‐induced macrophage exhaustion
Padovani, C. M., Wilson, R. M., Rodríguez, A. R., Spur, B. W., & Yin, K. (2024) · The FASEB Journal · doi:10.1096/fj.202302521r · Cited by 13
Mahardhika, A. B., Załuski, M., Schoeder, C. T., Boshta, N. M., Schabikowski, J., Perri, F., Łażewska, D., Neumann, A., Kremers, S., Oneto, A., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c02423 · Cited by 12
Recombinant human thrombomodulin attenuated sepsis severity in a non-surgical preterm mouse model
Ashina, M., Fujioka, K., Nishida, K., Okubo, S., Ikuta, T., Shinohara, M., & Iijima, K. (2020) · Scientific Reports · doi:10.1038/s41598-019-57265-2 · Cited by 12
Metadata
- Authors
- Spite, M., Norling, L. V., Summers, L., Yang, R., Cooper, D., Petasis, N. A., Flower, R. J., Perretti, M., & Serhan, C. N.
- Affiliations
- Brigham and Women's Hospital (US)
- Queen Mary University of London (GB)
- University of Southern California (US)
- Corresponding author
- Serhan, Charles N.
- ORCID
- Venue
- Nature
- Published
- 2009-10
- Volume
- 461
- Issue
- 7268
- Pages
- 1287-1291
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC2779525
- OpenAlex
- W1974226247
- Cited by
- 695
- References
- 33
- Citations by year
- 2026: 21 · 2025: 19 · 2024: 35 · 2023: 34 · 2022: 42 · 2021: 49 · 2020: 61 · 2019: 40 · 2018: 40 · 2017: 44 · 2016: 54 · 2015: 45 · 2014: 39 · 2013: 50 · 2012: 48
- FWCI
- 38.72
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Queen Mary Research Online (Queen Mary University of London) (submittedVersion)
- Funders
- Wellcome Trust (086867/Z/08/Z, 085903/Z/08)
- Versus Arthritis (18445, 18103)
- National Institutes of Health (4r37gm038765-19)
- National Heart, Lung, and Blood Institute (HL087526, F32HL087526)
- National Institute of General Medical Sciences (GM 38765, R01GM038765, R37-GM038765)
- National Institute of Dental and Craniofacial Research (P50DE016191)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Keywords
- resolvin D2, inflammation resolution, neutrophil trafficking, leukocyte-endothelium interaction, nitric oxide, leukocyte adhesion molecules, cecal ligation and puncture, bacterial load, macrophage phagocytosis, anti-inflammatory agents, host defense
- MeSH terms
- Animals, Docosahexaenoic Acids, Escherichia coli, Humans, Inflammation, Leukocytes, Macrophages, Male, Mice, Inbred C57BL, Nitric Oxide, Peritoneal Cavity, Peritonitis, Phagocytosis, Reactive Oxygen Species, Sepsis, Endothelial Cells, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review